We are live on ! Find out more
NERM

New England Research & Management Portfolio holdings

AUM $257M
1-Year Est. Return 25.66%
This Fund
S&P 500
This Quarter Est. Return
+7.9%
1 Year Est. Return
+25.66%
3 Year Est. Return
+56.38%
5 Year Est. Return
+58.71%
10 Year Est. Return
+176.32%
AUM
$218M
AUM Growth
+$7.19M
Cap. Flow
-$6.19M
Cap. Flow %
-2.85%
Top 10 Hldgs %
29.01%
Holding
178
New
31
Increased
32
Reduced
56
Closed
32

Top Buys

Rank Stock Value
1
LULU icon
lululemon athletica
LULU
+$1.99M
2
GEV icon
GE Vernova
GEV
+$1.94M
3
COF icon
Capital One
COF
+$1.52M
4
ARW icon
Arrow Electronics
ARW
+$1.52M
5
DHI icon
D.R. Horton
DHI
+$1.35M

Top Sells

Rank Stock Value
1
GS icon
Goldman Sachs
GS
+$3.92M
2
UNH icon
UnitedHealth
UNH
+$2.06M
3
TOL icon
Toll Brothers
TOL
+$1.98M
4
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$1.92M
5
FTNT icon
Fortinet
FTNT
+$1.57M

Sector Composition

Rank Sector Weight
1 Industrials 21.6%
2 Technology 15.11%
3 Healthcare 14.51%
4 Financials 12.59%
5 Consumer Discretionary 12.05%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LIN icon
76
Linde
LIN
$213B
$979K 0.45%
2,060
-270
-12% -$128K
MA icon
77
Mastercard
MA
$502B
$970K 0.45%
1,705
-10
-0.6% -$5.74K
INDB icon
78
Independent Bank
INDB
$3.96B
$938K 0.43%
13,565
-200
-1% -$13.6K
RY icon
79
Royal Bank of Canada
RY
$283B
$928K 0.43%
6,300
UPS icon
80
United Parcel Service
UPS
$87.1B
$903K 0.41%
10,810
-1,850
-15% -$168K
PNR icon
81
Pentair
PNR
$9.03B
$892K 0.41%
8,050
BSX icon
82
Boston Scientific
BSX
$63.6B
$891K 0.41%
9,128
-1,422
-13% -$147K
NCLH icon
83
Norwegian Cruise Line
NCLH
$6.56B
$883K 0.41%
+35,850
New +$871K
PB icon
84
Prosperity Bancshares
PB
$8.53B
$823K 0.38%
12,400
+9,425
+317% +$648K
AIR icon
85
AAR Corp
AIR
$4.67B
$823K 0.38%
9,175
-2,150
-19% -$164K
FANG icon
86
Diamondback Energy
FANG
$59.2B
$719K 0.33%
+5,025
New +$715K
LEU icon
87
Centrus Energy
LEU
$2.91B
$690K 0.32%
+2,225
New +$492K
FTNT icon
88
Fortinet
FTNT
$126B
$690K 0.32%
8,205
-17,575
-68% -$1.57M
VEEV icon
89
Veeva Systems
VEEV
$43.2B
$670K 0.31%
+2,250
New +$633K
CL icon
90
Colgate-Palmolive
CL
$69.4B
$663K 0.3%
8,288
PEP icon
91
PepsiCo
PEP
$185B
$660K 0.3%
4,696
-280
-6% -$40K
CWEN icon
92
Clearway Energy Class C
CWEN
$6.14B
$650K 0.3%
+23,000
New +$697K
FCX icon
93
Freeport-McMoran
FCX
$99.6B
$620K 0.28%
+15,800
New +$685K
CCL icon
94
Carnival Corporation Ltd
CCL
$30.3B
$619K 0.28%
+21,400
New +$646K
EMR icon
95
Emerson Electric
EMR
$82B
$618K 0.28%
4,708
CRH icon
96
CRH
CRH
$58.3B
$614K 0.28%
+5,125
New +$541K
IBP icon
97
Installed Building Products
IBP
$5.31B
$610K 0.28%
2,475
+550
+29% +$131K
AMT icon
98
American Tower
AMT
$82.8B
$606K 0.28%
3,150
VRTX icon
99
Vertex Pharmaceuticals
VRTX
$130B
$601K 0.28%
1,535
+475
+45% +$199K
CSCO icon
100
Cisco
CSCO
$434B
$598K 0.27%
8,740

Similar funds

New England Research & Management's Q3 2025 Portfolio in Review

As of Q3 2025, New England Research & Management held 178 positions worth $218M, up 3.4% from $211M the previous quarter. Its ten largest holdings account for 29% of the portfolio.

New England Research & Management's Q3 2025 filing shows 31 new, 32 increased, 56 reduced and 32 closed positions. Its largest new stake was lululemon athletica: 9,950 shares worth $1.77M. The largest sale was Goldman Sachs, an estimated $3.92M.

By sector, the portfolio is most concentrated in Industrials at 22% of assets, up from 21% a quarter earlier, followed by Technology and Healthcare.

  • New England Research & Management's largest Q3 2025 buy was lululemon athletica: 9,950 shares worth $1.77M.
  • New England Research & Management added most to GE Vernova in Q3 2025, an estimated $1.94M increase.
  • New England Research & Management's biggest Q3 2025 reduction was Goldman Sachs, cutting an estimated $3.92M.
  • New England Research & Management fully exited Teradyne in Q3 2025, selling an estimated $1.55M.
  • New England Research & Management's ten largest holdings make up 29% of its $218M portfolio in Q3 2025.
  • New England Research & Management opened 31 new positions and closed 32 in Q3 2025.
  • New England Research & Management's portfolio value rose 3.4% quarter-over-quarter to $218M.

Based on New England Research & Management's 13F filing for Q3 2025, filed 6 Oct 2025.